Login
$ARTV
$3.94 -$0.02 (0.51%) After hours

$ARTV SEC Filings

Filed On Filing
09 Nov 2026 8-K/A: Costs Associated with Exit or Disposal Activities

On October 27, 2026, Artiva Biotherapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) with the Securities and Exchange Commission (the “SEC”) disclosing that the Company’s board of directors approved t...

09 Nov 2026 10-Q
03 Nov 2026 Form 4: Horan Christopher, Chief Tech Operations Officer

Sold 10,423 shares ($43.6K)

03 Nov 2026 Form 4: Bush Jennifer, COO, CLO, Compliance Officer

Sold 8,439 shares ($35.3K)

03 Nov 2026 Form 4: Banerjee Subhashis, Chief Medical Officer

Sold 1,110 shares ($4.64K)

03 Nov 2026 Form 4: Aslan Fred, Director

Sold 62,178 shares ($260K)

27 Oct 2026 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities

Company halting further development of AlloNK® (AB-101), including the planned phase 3 pivotal trial

07 Oct 2026 Form 4: Aslan Fred, Director

Sold 23,463 shares ($169K)

06 Oct 2026 144
06 Oct 2026 Form 4: Horan Christopher, Chief Tech Operations Officer

Sold 10,340 shares ($70.7K)

06 Oct 2026 Form 4: Bush Jennifer, COO, CLO, Compliance Officer

Sold 8,370 shares ($57.2K)

06 Oct 2026 Form 4: Banerjee Subhashis, Chief Medical Officer

Sold 1,099 shares ($7.51K)

06 Oct 2026 Form 4: Aslan Fred, Director

Sold 61,696 shares ($422K)

15 Sep 2026 Form 4: Aslan Fred, Director

Received 110,000 shares as a grant or award · Granted 315,000 Employee Stock Option (Right to Buy)

14 Sep 2026 Form 4: Aslan Fred, Director

Received 45,000 shares as a grant or award · Granted 155,000 Employee Stock Option (Right to Buy)

14 Sep 2026 Form 4: Ra Capital MANAGEMENT, L.p., Director and 5 others

Granted 16,250 Director Stock Option (Right to Buy)

14 Sep 2026 Form 4: Stoppel Laura, Director

Granted 16,250 Director Stock Option (Right to Buy)

14 Sep 2026 Form 4: Sorg Elaine K., Director

Granted 16,250 Director Stock Option (Right to Buy)

14 Sep 2026 Form 4: Hougen Elizabeth L, Director

Granted 16,250 Director Stock Option (Right to Buy)

14 Sep 2026 Form 4: Daniels Brian, Director

Granted 16,250 Director Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support